Okada Ichiro, Inoue Junichi, Kato Hiroshi, Koido Yuichi, Kiriu Nobuaki, Hattori Takayuki, Morimoto Kohei, Ichinose Yoshiaki, Yokota Hiroyuki
Department of Critical Care Medicine and Trauma, National Hospital Organization Disaster Medical Center.
Emergency and Critical Care Medical Center, Yamanashi Prefectural Central Hospital.
J Nippon Med Sch. 2019;86(3):172-178. doi: 10.1272/jnms.JNMS.2019_86-306.
Renal artery stenting is performed for renal artery injuries to preserve renal function and prevent renovascular hypertension. However, its indications are controversial and its long-term prognosis remains unknown. Here, we evaluate the characteristics and long-term outcomes of renal artery stenting for blunt renal artery injuries at our institution.
We retrospectively reviewed patients with blunt renal artery injuries who had been treated with stenting over a 12-year period at our institution. Five patients (three men and two women) were included.
Trauma resulted from falls in three patients and motor vehicle accidents in two. All patients had experienced multiple injuries (median injury severity score, 24 [range, 16-48]; median revised trauma score, 5.9672 [4.0936-7.8408]; and median probability of survival, 0.689 [0.533-0.980]). All renal artery injuries involved stenosis because of traumatic arterial dissection or intimal tear; no cases of total occlusion were observed. No complications due to the intervention itself were observed. Although two patients developed reversible acute renal failure, none required long-term hemodialysis. One patient with renovascular hypertension was treated with antihypertensive agents for a month and subsequently became normotensive without further medication. All patients underwent postoperative computed tomography, which revealed no stent occlusion or renal atrophy. Renal scintigraphy for three patients demonstrated preserved differential renal function. All five patients survived.
Renal artery stenting for hemodynamically stable blunt renal artery injuries with stenosis is suggested to be safe and helps in avoiding long-term hemodialysis and renovascular hypertension.
肾动脉支架置入术用于治疗肾动脉损伤,以保护肾功能并预防肾血管性高血压。然而,其适应证存在争议,长期预后仍不明确。在此,我们评估了我院钝性肾动脉损伤患者行肾动脉支架置入术的特点及长期预后。
我们回顾性分析了我院12年间接受支架置入术治疗的钝性肾动脉损伤患者。共纳入5例患者(3例男性,2例女性)。
3例患者因跌倒受伤,2例因机动车事故受伤。所有患者均有多处损伤(损伤严重程度评分中位数为24[范围16 - 48];改良创伤评分中位数为5.9672[4.0936 - 7.8408];生存概率中位数为0.689[0.533 - 0.980])。所有肾动脉损伤均因创伤性动脉夹层或内膜撕裂导致狭窄;未观察到完全闭塞病例。未观察到因介入操作本身引起的并发症。虽然2例患者出现可逆性急性肾衰竭,但均无需长期血液透析。1例肾血管性高血压患者接受了1个月的抗高血压药物治疗,随后血压恢复正常,无需进一步药物治疗。所有患者术后均行计算机断层扫描,结果显示无支架闭塞或肾萎缩。3例患者的肾闪烁显像显示肾功能差异保留。所有5例患者均存活。
对于血流动力学稳定的伴有狭窄的钝性肾动脉损伤患者,肾动脉支架置入术被认为是安全的,有助于避免长期血液透析和肾血管性高血压。